INS and obesity disorder: Studies indicate that Blautia can inhibit insulin signaling and fat accumulation in adipocytes by activating G protein-coupled receptors GPR41 and GPR43, promoting lipid and glucose metabolism in other tissues, and alleviating obesity-related complications, particularly those associated with inflammation [59, 60].